Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Humana ( (HUM) ) has shared an update.
Humana Inc. reported its financial results for the third quarter of 2025, with an EPS of $1.62 on a GAAP basis and $3.24 on an adjusted basis. The company updated its full-year 2025 GAAP EPS guidance to approximately $12.26, while affirming its adjusted EPS guidance of approximately $17.00. Humana also revised its Medicare Advantage membership decline forecast to a smaller decrease of approximately 425,000 members, citing stronger retention and sales. The company is advancing its long-term strategy with growth in CenterWell and Medicaid businesses, and is preparing for new program launches in early 2026.
The most recent analyst rating on (HUM) stock is a Buy with a $326.00 price target. To see the full list of analyst forecasts on Humana stock, see the HUM Stock Forecast page.
Spark’s Take on HUM Stock
According to Spark, TipRanks’ AI Analyst, HUM is a Outperform.
Humana’s overall stock score is driven by strong financial performance and a positive earnings call, highlighting strategic growth in Medicaid and improved EPS guidance. Technical analysis and valuation are neutral, with no significant signals of overvaluation or undervaluation. Ongoing litigation and home health rate challenges are risks to monitor.
To see Spark’s full report on HUM stock, click here.
More about Humana
Humana Inc. operates in the healthcare industry, focusing on health insurance services, including Medicare Advantage plans and Medicaid. The company is expanding its CenterWell and Medicaid businesses, and is preparing for new program launches in Michigan, Illinois, and South Carolina.
Average Trading Volume: 1,778,896
Technical Sentiment Signal: Sell
Current Market Cap: $33.9B
For an in-depth examination of HUM stock, go to TipRanks’ Overview page.